ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

American Radium Society Abstracts

July 23, 1976

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

Bloch Dissatisfied With PDQ, Offers $1 Million To fund “Tailored” Treatment Data To Physicians

November 13, 1987

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

NCAB Approves CIS Recompetition, Restructuring

May 17, 1991